Amphastar, in letters sent to the FDA in April and June, cited some public contacts and email between Dr. Woodcock and one of Momenta's founders, Massachusetts Institute of Technology biological engineering professor Ram Sasisekharan, beginning in February 2007. Among those contacts were their attendance at an international medical conference in Thailand in November 2007.
Do you suggest that FDA employees avoid any medical conference that MIT professors or biotech/pharma scientists attend?
i.e.., Forget ASCO, ASH, or any meeting listed in the Scientific Calendar... #msg-39729635